Issay Kitabayashi

机构：Fujita Health University · ORCID：0000-0002-8409-0407

发表论文 189 篇 · 总被引 8039 次 · h-index 46

代表论文

• Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors (2022 · Molecular Therapy — Oncolytics · 被引 31)
• MOZ is critical for the development of MOZ/MLL fusion–induced leukemia through regulation of Hoxa9/Meis1 expression (2022 · Blood Advances · 被引 14)
• Dual inhibition of EZH1/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1 (2022 · International Journal of Hematology · 被引 9)
• Polycomb repressive complexes as therapeutic targets in hematologic malignancies (2025 · Experimental Hematology · 被引 6)
• Regulation of H3K4me3 breadth and MYC expression by the SETD1B catalytic domain in MLL-rearranged leukemia (2025 · Leukemia · 被引 5)
• Loss of NOL10 leads to impaired disease progression of NUP98::DDX10 leukemia (2025 · Leukemia · 被引 3)